Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial

Reduced Dose ◽

Receptor Inhibition ◽

Platelet Receptor

Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.20101 ◽

2004 ◽

Vol 62 (4) ◽

pp. 445-452 ◽

Cited By ~ 12

Author(s):

Aaron Wong ◽

Koon-Hou Mak ◽

Charles Chan ◽

Tian-Hai Koh ◽

Kean-Wah Lau ◽

...

Keyword(s):

Myocardial Infarction ◽

Pilot Study ◽

Primary Angioplasty ◽

Asia Pacific ◽

Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization

International Journal of Cardiovascular Interventions ◽

10.1080/146288401316922634 ◽

2001 ◽

Vol 4 (1) ◽

pp. 7-14

Author(s):

Abdulhay Albirini, Sorin J Brener

Keyword(s):

Myocardial Infarction ◽

Primary Angioplasty ◽

Platelet Glycoprotein ◽

New Paradigm ◽

Receptor Inhibition

Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction

JAMA ◽

10.1001/jama.288.17.2130 ◽

2002 ◽

Vol 288 (17) ◽

pp. 2130 ◽

Cited By ~ 91

Author(s):

A. Michael Lincoff ◽

Robert M. Califf ◽

Frans Van de Werf ◽

James T. Willerson ◽

Harvey D. White ◽

...

Keyword(s):

Myocardial Infarction ◽

Fibrinolytic Therapy ◽

Platelet Glycoprotein ◽

Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction

The American Journal of Cardiology ◽

10.1016/s0002-9149(02)02241-5 ◽

2002 ◽

Vol 89 (8) ◽

pp. 930-936 ◽

Cited By ~ 7

Author(s):

Koon-Hou Mak ◽

Lai-Heng Lee ◽

Aaron Wong ◽

Charles Chan ◽

Tian-Hai Koh ◽

...

Keyword(s):

Myocardial Infarction ◽

Thrombin Generation ◽

Potent P2Y12 Receptor Inhibition in Korean Patients with Acute Myocardial Infarction

Korean Circulation Journal ◽

10.4070/kcj.2019.0301 ◽

2019 ◽

Vol 49 (12) ◽

pp. 1199 ◽

Cited By ~ 1

Author(s):

Yongcheol Kim ◽

Thomas W. Johnson ◽

Myung Ho Jeong

Keyword(s):

Myocardial Infarction ◽

P2y12 Receptor ◽

Korean Patients ◽

Receptor Inhibition

Reduced dose tenecteplase plus tirofiban achieves similar TIMI 3 flow to full dose tenecteplase alone in acute myocardial infarction

Evidence-based Cardiovascular Medicine ◽

10.1016/j.ebcm.2005.09.028 ◽

2005 ◽

Vol 9 (4) ◽

pp. 271-272

Keyword(s):

Myocardial Infarction ◽

Full Dose ◽

Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study

Canadian Journal of Cardiology ◽

10.1016/s0828-282x(09)70536-7 ◽

2009 ◽

Vol 25 (12) ◽

pp. e417-e421 ◽

Cited By ~ 7

Author(s):

Thao Huynh ◽

James Nasmith ◽

The Minh Luong ◽

Martin Bernier ◽

Chantal Pharand ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndromes ◽

Signs And Symptoms ◽

Receptor Inhibition ◽

St Segment ◽

Platelet Receptor ◽

Coronary Syndromes ◽

St Elevation ◽

Timi Risk Score ◽

Ischemic Syndrome

Intravenous adenosine diphosphate P2T platelet receptor antagonism as an adjunct to fibrinolysis for acute myocardial infarction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(02)81260-8 ◽

2002 ◽

Vol 39 ◽

pp. 281 ◽

Cited By ~ 2

Author(s):

Adam B. Greenbaum ◽

E.M. Ohman ◽

Michael S. Gibson ◽

Steven L. Borzak ◽

Michel LeMay ◽

...

Keyword(s):

Myocardial Infarction ◽

Adenosine Diphosphate ◽

Receptor Antagonism ◽

Platelet Receptor

Author's Reply to Potent P2Y12 Receptor Inhibition in Korean Patients with Acute Myocardial Infarction

Korean Circulation Journal ◽

10.4070/kcj.2019.3011 ◽

2019 ◽

Vol 49 (12) ◽

pp. 1201

Author(s):

Kyeong Ho Yun ◽

Sang Jae Rhee

Keyword(s):

Myocardial Infarction ◽

P2y12 Receptor ◽

Korean Patients ◽

Receptor Inhibition

3651 Platelet receptor glycoprotein IIb/IIIa inhibition assessed with RFPA during novel administration of tirofiban in patients with acute myocardial infarction treated with primary coronary angioplasty

European Heart Journal ◽

10.1016/s0195-668x(03)96235-x ◽

2003 ◽

Vol 24 (5) ◽

pp. 713

Author(s):

P KRALISZ

Keyword(s):

Myocardial Infarction ◽

Coronary Angioplasty ◽

Platelet Receptor ◽

Primary Coronary Angioplasty